☰

Jyoti B. Patel, Ph.D. - Publications

Affiliations: 
2005 University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Pharmacology, Oncology
Tree Info Grants Similar researchers PubMed Report error

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2017 Simmons JK, Michalowski AM, Gamache BJ, DuBois W, Patel J, Zhang K, Gary J, Zhang S, Gaikwad S, Connors D, Watson N, Leon E, Chen JQ, Kuehl WM, Lee MP, et al. Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation. Molecular Cancer Therapeutics. PMID 28522584 DOI: 10.1158/1535-7163.MCT-17-0171  0.371
2014 Ou O, Huppi K, Chakka S, Gehlhaus K, Dubois W, Patel J, Chen J, Mackiewicz M, Jones TL, Pitt JJ, Martin SE, Goldsmith P, Simmons JK, Mock BA, Caplen NJ. Loss-of-function RNAi screens in breast cancer cells identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as sensitizing targets of rapamycin activity. Cancer Letters. 354: 336-47. PMID 25193464 DOI: 10.1016/j.canlet.2014.08.043  0.368
2014 Simmons JK, Patel J, Michalowski A, Zhang S, Wei BR, Sullivan P, Gamache B, Felsenstein K, Kuehl WM, Simpson RM, Zingone A, Landgren O, Mock BA. TORC1 and class I HDAC inhibitors synergize to suppress mature B cell neoplasms. Molecular Oncology. 8: 261-72. PMID 24429254 DOI: 10.1016/J.Molonc.2013.11.007  0.307
2012 Patel JB, Patel KD, Patel SR, Shah FD, Shukla SN, Patel PS. Recent candidate molecular markers: vitamin D signaling and apoptosis specific regulator of p53 (ASPP) in breast cancer. Asian Pacific Journal of Cancer Prevention : Apjcp. 13: 1727-35. PMID 22901112 DOI: 10.7314/APJCP.2012.13.5.1727  0.336
2012 Purushottamachar P, Patel JB, Gediya LK, Clement OO, Njar VC. First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): identification of novel RAMBA scaffolds. European Journal of Medicinal Chemistry. 47: 412-23. PMID 22130607 DOI: 10.1016/J.Ejmech.2011.11.010  0.637
2008 Gediya LK, Khandelwal A, Patel J, Belosay A, Sabnis G, Mehta J, Purushottamachar P, Njar VC. Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro. Journal of Medicinal Chemistry. 51: 3895-904. PMID 18543902 DOI: 10.1021/Jm8001839  0.703
2007 Patel JB, Mehta J, Belosay A, Sabnis G, Khandelwal A, Brodie AM, Soprano DR, Njar VC. Novel retinoic acid metabolism blocking agents have potent inhibitory activities on human breast cancer cells and tumour growth. British Journal of Cancer. 96: 1204-15. PMID 17387344 DOI: 10.1038/Sj.Bjc.6603705  0.719
2007 Patel JB, Khandelwal A, Chopra P, Handratta VD, Njar VC. Murine toxicology and pharmacokinetics of novel retinoic acid metabolism blocking agents. Cancer Chemotherapy and Pharmacology. 60: 899-905. PMID 17345084 DOI: 10.1007/S00280-007-0438-3  0.736
2006 Njar VC, Gediya L, Purushottamachar P, Chopra P, Belosay A, Patel JB. Retinoids in clinical use. Medicinal Chemistry (ShāRiqah (United Arab Emirates)). 2: 431-8. PMID 16848757 DOI: 10.2174/157340606777724022  0.609
2006 Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, Mehta J, Huynh C, Belosay A, Patel J. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorganic & Medicinal Chemistry. 14: 4323-40. PMID 16530416 DOI: 10.1016/J.Bmc.2006.02.041  0.719
2006 Njar VCO, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, Mehta J, Huynh C, Belosay A, Patel J. Retinoic Acid Metabolism Blocking Agents (RAMBAs) for Treatment of Cancer and Dermatological Diseases Cheminform. 37. DOI: 10.1002/CHIN.200637236  0.739
2005 Kalra KB, Cheng X, Womak M, Gocke C, Patel JB, Njar VCO, Takebe N. Novel Retinoic Acid Metabolism Blocking Agents (RAMBAs) Induce Differentiation in ATRA Resistant Cell Line: Potential New Theraputics for Acute Promyleocytic Leukemia (APL). Blood. 106: 746-746. DOI: 10.1182/Blood.V106.11.746.746  0.506
2004 Patel JB, Huynh CK, Handratta VD, Gediya LK, Brodie AM, Goloubeva OG, Clement OO, Nanne IP, Soprano DR, Njar VC. Novel retinoic acid metabolism blocking agents endowed with multiple biological activities are efficient growth inhibitors of human breast and prostate cancer cells in vitro and a human breast tumor xenograft in nude mice. Journal of Medicinal Chemistry. 47: 6716-29. PMID 15615521 DOI: 10.1021/Jm0401457  0.75
2003 Raval GN, Patel DD, Parekh LJ, Patel JB, Shah MH, Patel PS. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer. Oral Diseases. 9: 119-28. PMID 12945593 DOI: 10.1034/J.1601-0825.2003.01795.X  0.306
Show low-probability matches.